Mark L. Baum, Director at Eton Pharmaceuticals, Inc. (ETON), bought 10,000 shares at $6.00 ($60K) on 2018-11-15, disclosed to the SEC on 2018-11-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| HROW | BUY | 2023-11-16 | $122K | — | Filing → |
| HROW | BUY | 2023-08-15 | $99K | — | Filing → |
| HROW | BUY | 2022-12-23 | $335K | — | Filing → |